CLSI POCT4 A2 : 2ED 2006
Superseded
A superseded Standard is one, which is fully replaced by another Standard, which is a new edition of the same Standard.
View Superseded by
POINT-OF-CARE IN VITRO DIAGNOSTIC (IVD) TESTING
30-06-2016
12-01-2013
Abstract
Committee Membership
Foreword
1 Scope
2 Introduction
3 Standard Precautions
4 Definitions
4.1 Abbreviations and Acronyms
5 POCT Consideration
6 Regulatory Considerations
7 Development of Policy
7.1 Designate Authority
7.2 Assign Responsibility
7.3 Maintain Accountability
8 Procedures
9 Organizational Structure
9.1 Hospital-Based POCT
9.2 Nonhospital-Based POCT
10 Personnel Considerations
10.1 Hospital Setting
10.2 POCT Personnel Outside the Hospital
11 Method and Instrument Considerations and Selection
11.1 Gathering Information
11.2 Beginning the Process
12 Training
13 Cost Accounting Considerations
14 Cost/Benefit Analysis
15 Safety and Waste Disposal
15.1 Safety
15.2 Exposure-Incident Follow-up
15.3 Avoiding Accidental Skin Puncture With Sharps
15.4 Personal Protective Equipment
15.5 Handwashing/Sanitizing
15.6 Food, Drink, Cigarettes, and Cosmetics
15.7 Routine Cleaning and Disposal
15.8 Infectious Waste Handling and Disposal
15.9 Electrical Precautions
15.10 Safety Manual
16 Patient/Client Preparation/Specimen Collection and
Identification
16.1 Patient/Client Preparation and Identification
16.2 Specimen Collection
16.3 Specimen Identification
16.4 Special Precautions
17 Calibration and Calibration Verification
17.1 Calibration
17.2 Calibration Verification
17.3 Frequency of Calibration and Calibration Verification
18 Quality Control
18.1 Purpose of Controls
18.2 Applicability of QC Procedures
18.3 Considerations in Designing a QC Program
18.4 Guidelines for QC Applied to Various Testing Devices
19 Reportable Range
20 Maintenance
21 Evaluation/Surveillance of Proficiency
22 Result Reporting/Recordkeeping
22.1 Confidentiality
22.2 Reporting and Forms
22.3 Reporting Test Results
22.4 Medical Alert Values
23 Interpretation of Results
24 Quality Control Documentation
24.1 QC Documentation
25 Quality Assurance
25.1 General Recommendations for QA
25.2 QA Documentation
26 Risk Management/Liability
References
Additional References
Appendix A - Sample Procedure Format
Appendix B - Sample QC Log Sheet
Appendix C - Sample Preventive Maintenance Record Form
Appendix D - Sources for Practice Parameters and American
College of Physicians Guidelines
Appendix E - Point-of-Care Training Checklist
Summary of Delegate Comments and Subcommittee Responses
The Quality System Approach
Related CLSI/NCCLS Publications
Provides guidance to users of in vitro diagnostic (IVD) devices outside the clinical laboratory, to ensure reliable results comparable to those obtained within the clinical laboratory.
DevelopmentNote |
Supersedes NCCLS AST2 A (09/2006) Supersedes NCCLS AST3 A. (05/2011)
|
DocumentType |
Miscellaneous Product
|
PublisherName |
Clinical Laboratory Standards Institute
|
Status |
Superseded
|
SupersededBy | |
Supersedes |
CLSI MM19 A : 1ED 2011 | ESTABLISHING MOLECULAR TESTING IN CLINICAL LABORATORY ENVIRONMENTS |
ISO 16142-2:2017 | Medical devices — Recognized essential principles of safety and performance of medical devices — Part 2: General essential principles and additional specific essential principles for all IVD medical devices and guidance on the selection of standards |
ASTM E 2538 : 2006 : R2011 | Standard Practice for Defining and Implementing Pharmacotherapy Information Services within the Electronic Health Record (EHR) Environment and Networked Architectures (Withdrawn 2020) |
CLSI NBS06 A : 1ED 2013 | NEWBORN BLOOD SPOT SCREENING FOR SEVERE COMBINED IMMUNODEFICIENCY BY MEASUREMENT OF T-CELL RECEPTOR EXCISION CIRCLES |
CLSI POCT9 A : 1ED 2010 | SELECTION CRITERIA FOR POINT-OF-CARE TESTING DEVICES |
CLSI MM17 P : 1ED 2007 | VERIFICATION AND VALIDATION OF MULTIPLEX NUCLEIC ACID ASSAYS |
ANSI/AAMI/ISO 16142-2:2017 | MEDICAL DEVICES - RECOGNIZED ESSENTIAL PRINCIPLES OF SAFETY AND PERFORMANCE OF MEDICAL DEVICES - PART 2: GENERAL ESSENTIAL PRINCIPLES AND ADDITIONAL SPECIFIC ESSENTIAL PRINCIPLES FOR ALL IVD MEDICAL DEVICES AND GUIDANCE ON THE SELECTION OF STANDARDS |
ASTM E 2538 : 2006 | Standard Practice for Defining and Implementing Pharmacotherapy Information Services within the Electronic Health Record (EHR) Environment and Networked Architectures |
CLSI POCT9 P : 1ED 2009 | SELECTION CRITERIA FOR POINT-OF-CARE TESTING DEVICES |
BS ISO 16142-2:2017 | Medical devices. Recognized essential principles of safety and performance of medical devices General essential principles and additional specific essential principles for all IVD medical devices and guidance on the selection of standards |
CLSI MM17 A : 1ED 2008 | VERIFICATION AND VALIDATION OF MULTIPLEX NUCLEIC ACID ASSAYS |
CLSI H3 A5 : 5ED 2003 | PROCEDURES FOR THE COLLECTION OF DIAGNOSTIC BLOOD SPECIMENS BY VENIPUNCTURE |
CLSI GP16 A2 : 2ED 2001 | ROUTINE URINALYSIS AND COLLECTION, TRANSPORTATION, AND PRESERVATION OF URINE SPECIMENS |
CLSI GP11 A : 1ED 98 | BASIC COST ACCOUNTING FOR CLINICAL SERVICES |
CLSI POCT13 A2 : 2ED 2005 | GLUCOSE MONITORING IN SETTINGS WITHOUT LABORATORY SUPPORT |
CLSI M29 A3 : 3ED 2005 | ACQUIRED INFECTIONS; APPROVED GUIDELINE |
CLSI GP21 A2 : 2ED 2004 | TRAINING AND COMPETENCE ASSESSMENT |
CLSI HS1 A2 : 2ED 2004 | A QUALITY MANAGEMENT SYSTEM MODEL FOR HEALTH CARE |
CLSI C30 A2 : 2ED 2002 | POINT-OF-CARE BLOOD GLUCOSE TESTING IN ACUTE AND CHRONIC CARE FACILITIES |
CLSI GP26 A3 : 3ED 2004 | APPLICATION OF A QUALITY MANAGEMENT SYSTEM MODEL FOR LABORATORY SERVICES |
CLSI H4 A3 : 1991 | PROCEDURES FOR THE COLLECTION OF DIAGNOSTIC BLOOD SPECIMENS BY SKIN PUNCTURE |
CLSI C24 A3 : 3ED 2006 | STATISTICAL QUALITY CONTROL FOR QUANTITATIVE MEASUREMENT PROCEDURES: PRINCIPLES AND DEFINITIONS |
CLSI H4 A5 : 5ED 2004 | PROCEDURES AND DEVICES FOR THE COLLECTION OF DIAGNOSTIC CAPILLARY BLOOD SPECIMENS |
CLSI EP18 A : 1ED 2002 | QUALITY MANAGEMENT FOR UNIT-USE TESTING |
CLSI EP9 A2 : 2ED 2002 | METHOD COMPARISON AND BIAS ESTIMATION USING PATIENT SAMPLES |
CLSI POCT14 A : 1ED 2004 | POINT-OF-CARE MONITORING OF ANTICOAGULATION THERAPY |
CLSI GP2 A5 : 5ED 2006 | LABORATORY DOCUMENTS - DEVELOPMENT AND CONTROL |
Access your standards online with a subscription
Features
-
Simple online access to standards, technical information and regulations.
-
Critical updates of standards and customisable alerts and notifications.
-
Multi-user online standards collection: secure, flexible and cost effective.